Literature DB >> 12037672

Physical interaction between pRb and cdk9/cyclinT2 complex.

Cristiano Simone1, Luigi Bagella, Cristiana Bellan, Antonio Giordano.   

Abstract

Cyclin-dependent kinase 9 (cdk9) is a multifunctional kinase with roles in different cellular pathways such as transcriptional elongation, differentiation and apoptosis. Cdk9/cyclin T differs functionally from other cdk/cyclin complexes that regulate cell cycle progression, but maintains structural affinity with those complexes. In addition, previous reports have demonstrated that the cdk9 complex is able to phosphorylate p56/pRb in vitro. In this report we show in vitro and in vivo interaction between cdk9/cyclinT2 and the protein product of the retinoblastoma gene (pRb) in human cell lines. The interaction involves the region composed of residues 129-195 of cdk9, cyclinT2 (1-642 aa) and the C-terminal domain of pRb (835-928 aa). We located the minimal region of cdk9 phosphorylation on the C-terminus of pRb, by identifying the residues between 793 and 834. This region contains at least three proline-directed serines (sp), S795, S807 and S811, which have been reported to be phosphorylated in vivo and which could be targeted by the cdk9 complex. These data suggest that, in logarithmically growing cells, cdk9/cyclin T2 and pRb are located in a nuclear multiprotein complex probably involved in transduction of cellular signals to the basal transcription machinery and that one of these signals could be the cdk9 phosphorylation of pRb.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12037672     DOI: 10.1038/sj.onc.1205511

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.

Authors:  Shun Ke; Rui-Chao Li; Jun Lu; Fan-Kai Meng; Yi-Kuan Feng; Ming-Hao Fang
Journal:  Int J Hematol       Date:  2017-04-13       Impact factor: 2.490

2.  CDKN1C negatively regulates RNA polymerase II C-terminal domain phosphorylation in an E2F1-dependent manner.

Authors:  Yihong Ma; Lu Chen; Gabriela M Wright; Smitha R Pillai; Srikumar P Chellappan; W Douglas Cress
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

3.  G-actin participates in RNA polymerase II-dependent transcription elongation by recruiting positive transcription elongation factor b (P-TEFb).

Authors:  Tianyang Qi; Wen Tang; Ling Wang; Lei Zhai; Lijing Guo; Xianlu Zeng
Journal:  J Biol Chem       Date:  2011-03-04       Impact factor: 5.157

4.  Downregulation of microRNA-142-3p and its tumor suppressor role in gastric cancer.

Authors:  Yi Wang; Zhidong Cao; Lanlan Wang; Siqi Liu; Jianqiang Cai
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

5.  Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function.

Authors:  James I Macdonald; Frederick A Dick
Journal:  Genes Cancer       Date:  2012-11

6.  The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2.

Authors:  Masanori Nojima; Yehong Huang; Mudit Tyagi; Hung-Ying Kao; Koh Fujinaga
Journal:  J Mol Biol       Date:  2008-07-16       Impact factor: 5.469

7.  The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties.

Authors:  Jitka Holcakova; Peter Tomasec; Joachim J Bugert; Eddie Cy Wang; Gavin Wg Wilkinson; Roman Hrstka; Vladimir Krystof; Miroslav Strnad; Borivoj Vojtesek
Journal:  Antivir Chem Chemother       Date:  2010-01-05

8.  Developmental regulators containing the I-mfa domain interact with T cyclins and Tat and modulate transcription.

Authors:  Qi Wang; Tara M Young; Michael B Mathews; Tsafi Pe'ery
Journal:  J Mol Biol       Date:  2007-01-12       Impact factor: 5.469

9.  A cyclin D2-Rb pathway regulates cardiac myocyte size and RNA polymerase III after biomechanical stress in adult myocardium.

Authors:  Ekaterini Angelis; Alejandro Garcia; Shing S Chan; Katja Schenke-Layland; Shuxen Ren; Sarah J Goodfellow; Maria C Jordan; Kenneth P Roos; Robert J White; W Robb MacLellan
Journal:  Circ Res       Date:  2008-04-17       Impact factor: 17.367

10.  P-TEFb- the final frontier.

Authors:  Jiri Kohoutek
Journal:  Cell Div       Date:  2009-09-02       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.